Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B brings in $7mm for Brickell Biotech

Executive Summary

Brickell Biotech Inc. (dermatology therapeutics) has raised $7mm through its Series B venture round. AmorePacific Ventures, the VC arm of Korean aesthetics and cosmetics company AmorePacific Corp., led and was joined by current shareholder Palisade Concentrated Equity Partnership (managed by Palisade Capital Management).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies